Relapsed / refractory osteosarcoma

Clinical trials for Relapsed / refractory osteosarcoma explained in plain language.

Never miss a new study

Get alerted when new Relapsed / refractory osteosarcoma trials appear

Sign up with your email to follow new studies for Relapsed / refractory osteosarcoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New radiation drug targets bone cancer cells directly

Disease control Recruiting now

This study tests a new drug called LNTH-2403, which delivers radiation directly to cancer cells in people with osteosarcoma (a type of bone cancer) that has returned or not responded to standard treatments. The drug is given as an injection and aims to shrink tumors or slow their…

Matched conditions: RELAPSED / REFRACTORY OSTEOSARCOMA

Phase 1/2 • Sponsor: Lantheus Medical Imaging • Aim: Disease control

Last updated Jun 27, 2026 12:28 UTC

Relapsed / refractory osteosarcoma

Get alerted when new Relapsed / refractory osteosarcoma trials appear

New radiation drug targets bone cancer cells directly